益气活血通脉汤对骨科大手术后下肢深静脉血栓的防治

徐国华; 陈品英; 田伟明; 柴仪

doi:10.11653/syfj2014040188

您当前的位置：

首页 >

文章列表页 >

益气活血通脉汤对骨科大手术后下肢深静脉血栓的防治

更新时间：2024-01-04

- 益气活血通脉汤对骨科大手术后下肢深静脉血栓的防治
- Clinic Research of Yiqi Huoxue Tongmai Decoction Prevention and Cure on Deep Venous Thrombosis after Major Orthopaedic Surgery
- 中国实验方剂学杂志 2014年20卷第4期页码：188-191
- 作者机构：
- 作者简介：
- 基金信息：
  
  河北省中医药管理局科技项目（2010093）
- DOI：10.11653/syfj2014040188
  中图分类号：
- 纸质出版日期：2014
- 稿件说明：
移动端阅览
徐国华, 陈品英, 田伟明, 等. 益气活血通脉汤对骨科大手术后下肢深静脉血栓的防治[J]. 中国实验方剂学杂志, 2014,20(4):188-191.

XU Guo-hua, CHEN Pin-ying, TIAN Wei-ming, et al. Clinic Research of Yiqi Huoxue Tongmai Decoction Prevention and Cure on Deep Venous Thrombosis after Major Orthopaedic Surgery[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(4): 188-191.
徐国华, 陈品英, 田伟明, 等. 益气活血通脉汤对骨科大手术后下肢深静脉血栓的防治[J]. 中国实验方剂学杂志, 2014,20(4):188-191. DOI： 10.11653/syfj2014040188.

XU Guo-hua, CHEN Pin-ying, TIAN Wei-ming, et al. Clinic Research of Yiqi Huoxue Tongmai Decoction Prevention and Cure on Deep Venous Thrombosis after Major Orthopaedic Surgery[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(4): 188-191. DOI： 10.11653/syfj2014040188.

摘要

目的：探讨益气活血通脉汤对骨科大手术后下肢深静脉血栓（DVT）形成的防治效果及作用机制。方法：将197例患者随机按住院前后顺序分为对照组96例和观察组101例。两组均进行常规DVT预防性措施，对照组采用低分子肝素钙注射液，手术前1~2 h，腹壁皮下注射2 500 U，手术后每天腹壁皮下注射2 500 IU，术后连续用药14 d。观察组在对照组治疗的基础上加服益气活血通脉汤，1剂/d，常规水煎分2次服用。两组疗程14 d。观察DVT形成情况，计算DVT发生率；观察术后伤肢肿胀程度；检测血清肿瘤坏死因子-α（TNF-α）、白细胞介素-1（IL-1）和白细胞介素-6（IL-6）水平；检查凝血功能和血清D-二聚体（D-D）。结果：术后第7天，观察组DVT发生率5.94%，低于对照组的15.62%（P<0.05）；术后第14 天观察组DVT发生率7.92%，低于对照组的22.91%（P<0.01）；术后第7，14天，观察组肿胀程度均轻于对照组（P<0.01）；术后第14天观察组血清TNF-α，IL-1和IL-6水平均低于对照组（P<0.01）；术后第14天，对照组纤维蛋白原（FIB）变化不明显，观察组FIB较术后第1天明显下降；两组术后第14天D-D均下降，观察组低于对照组（P<0.01）。结论：骨科大手术后使用益气活血通脉汤可减轻伤肿胀，降血清FIB和D-D水平，减轻炎性症反应，预防DVT的发生，值得临床使用。

Abstract

Objective: The purpose is to observe Yiqi Huoxue Tongmai decoction's prevention and cure on deep venous thrombosis(DVT)of control effect and mechanism action after major orthopaedic surgery. Method: One hundred and ninety-seven cases of patients were randomly divided into control group (96 cases) and observation group (101 cases) according to numeric method.Both groups were treated with regular DVT preventive measures.Besides control group injected Low-Molecular-Weight Heparins Calcium injection

1-2 hour before the operation

abdominal subcutaneous injection of 2 500 U

after the operation

patients treated with abdominal subcutaneous injection

2 500 U/day.The treatment course was 14 days.Based on control group

observation group added Yiqi Huoxue Tongmai decoction

1 does/day

conventional water decoction

orally.The treatment course was 14 days.Observe the form of DVT and record its occurrence rate.Observe the postoperative wound limb swelling degree.Detect serum tumor necrosis factor alpha (TNF-α)

interleukin-1(IL-1) and interleukin-6(IL-6).Check the blood coagulation function and serum D-dimer (D-D). Result: After the treatment

the occurrence rate of DVT in the 14 courses treatment of observation group was 7.9%

lower than 22.91% of the control group(P<0.01).At the seventh

fourteenth day of the surgery

degree of swelling of observation group were lighter than control group (P<0.01).At the fourteenth day of the surgery

the TNF-α

IL-1 and IL-6 of observation group were lower than control group (P<0.01). as for fibrinogen(FIB)

change is not obvious in control group

but in the observation group the FIB is reducing from the first day after the surgery.at the fourteenth day of the surgery

the D-D of both groups reduced

observation group was inferior to control group(P<0.01). Conclusion: Yiqi Huoxue Tongmai decoction can reduce injury swelling

serum levels of FIB and D-D

reduce the inflammatory reaction and prevent the happening of the DVT after major orthopaedic surgery.It deserves being used in clinic.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

补肺汤对慢性阻塞性肺疾病肺气虚证大鼠肺-肠轴的影响

沙参麦冬汤加减对阴虚肺热证肺炎支原体肺炎恢复期患者免疫炎症反应的影响

青蒿素对全身炎症反应综合征小鼠的保护作用

基于冠状病毒肺炎寒湿疫毒袭肺证病证结合模型的金柴抗病毒胶囊疗效评价

萆薢总皂苷对尿酸钠诱导THP-1细胞Toll样受体/核转录因子-κB(TLR/NF-κB)信号通路的影响